The Safest in Personalized and Predictive Insulin Dosing
Monarch Medical Technologies, the maker of the EndoTool® Glucose Management System, is the leading provider of precision insulin dosing technology for improved patient outcomes.
A True Precision Medicine Tool for Inpatient Glucose Management
Proven, patented algorithms to model, predict and adapt dosing recommendations to each patient and their individual response for more precise, safer inpatient insulin therapy.
Intravenous (IV) insulin dosing software to manage hyperglycemia while avoiding hypoglycemia
Basal-bolus subcutaneous insulin dosing software supporting industry guidelines and standards
Clinical Research & Case Studies
Demonstrated to Improve the Quality and Safety of Glucose Management
Learn MoreSpotlight
Check out the latest news and resources from the Monarch team and EndoTool users.
Upcoming Webinar
How Technology Can Support Adoption of Best Practices for Inpatient and Outpatient Insulin Management
In the complimentary June 25th webinar, presenters Dr. Mark Vanderwel and Amy Butts, PA-C, MPAS, CDE, BC-ADM will discuss the current challenges in initiating and managing insulin therapy, review the best practices, and discuss how technology can be used and implemented to benefit both patients and providers.
Register for the WebinarArticle
Patrick Burgess, MD: Hypoglycemia and Impact of Late Glucose Checks
Patrick Burgess, MD, PhD, inventor of EndoTool, sat down with MD Magazine to discuss his study on the impact of late blood glucose checks as well as other important topics being covered at the American Diabetes Association's 79th Scientific Sessions.
Read MoreClinical Research
Use of a Computer-Guided Glucose Management System to Improve Glycemic Control and Address National Quality Measures
A retrospective observational study evaluated the 7-year impact of the EndoTool® eGMS in intensive and intermediate units at Vidant Medical Center, a 900-bed tertiary teaching hospital.
Read More